Advertisement

Topics

BiondVax Pharmaceuticals Company Profile

21:01 EDT 22nd June 2018 | BioPortfolio


News Articles [489 Associated News Articles listed on BioPortfolio]

Biondvax Pharmaceuticals (BVXV) - Termination of coverage

Edison Investment Research - Pharmaceutical & healthcare - BiondVax Pharmaceuticals: Since BiondVax shares are no longer traded on the Tel Aviv Stock Exchange (TASE), Edison Investment Research Ltd. h...

BiondVax Pharmaceuticals Ltd: Wayne Rudolph explains their focus on development of a Universal Influenza vaccine.

In this episode of PharmaTelevision News Review, filmed at BIO 2011, Fintan Walton talks to Wayne Rudolph, Vice President of Corporate Development of BiondVax Pharmaceuticals Ltd.

BiondVax to Present at Universal Influenza Vaccines Conference

NESSZIONA, Israel, April 12, 2018/PRNewswire/ --  BiondVax Pharmaceuticals Ltd.(Nasdaq: BVXV), developer of the universal flu vaccine candidate M-001, reported Read more...

CRO Appointed To Conduct Trial Of Biondvax's Universal Flu Vaccine

NewsBiondVax Pharmaceuticals Ltd. developer of the Universal Flu Vaccine candidate M-001 has selected a CRO to conduct the Phase 3 Trial.

BiondVax Pharmaceuticals (BVXV) - Phase III for universal flu vaccine starts in 2018

Edison Investment Research - Pharmaceutical & healthcare - BiondVax Pharmaceuticals: Over 2017 BiondVax crystallised its late-stage development plans for lead asset M-001, a potentially universal infl...

Universal flu vaccine developer BiondVax signs CRO to advance Ph III trial

BiondVax is working closely with a CRO to advance its universal flu vaccine candidate, which will be manufactured in-house and in collaboration with a CMO to support tech-transfer pending a successful...

BiondVax signs CRO to advance universal flu vaccine candidate to Ph III trials

BiondVax is working closely with a CRO to advance its universal flu vaccine candidate, which will be manufactured in-house at the companyâs Israel-based facility and in collaboration with a CMO to su...

BiondVax Enters Agreement with CRO

To conduct the first pivotal, clinical efficacy, Phase 3 trial of M-001

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [133 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Environmental concentrations of pharmaceuticals directly affect phytoplankton and effects propagate through trophic interactions.

Pharmaceuticals are found in freshwater ecosystems where even low concentrations in the range of ng Lmay affect aquatic organisms. In the current study, we investigated the effects of chronic exposure...

Clinical Trials [216 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1322 Associated Companies listed on BioPortfolio]

BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd

BiondVax is a publicly traded (TASE: BNDX), advanced clinical stage biotech company dedicated to improving protection against influenza, with its lead product a universal influenza (flu) vaccine cal...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

More Information about "BiondVax Pharmaceuticals" on BioPortfolio

We have published hundreds of BiondVax Pharmaceuticals news stories on BioPortfolio along with dozens of BiondVax Pharmaceuticals Clinical Trials and PubMed Articles about BiondVax Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BiondVax Pharmaceuticals Companies in our database. You can also find out about relevant BiondVax Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record